Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes

NCT01238224 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

22

Enrollment

OTHER_GOV

Sponsor class

Stopped Durability of study medications could not be guaranteed after the expire date.

Conditions

Type 2 Diabetes

Interventions

DRUG: Tadalafil

Sponsor

Vastra Gotaland Region